Arquivos de gastroenterologia
Systematic review and brazilian expert consensus on the use of biosimilars in inflammatory bowel disease: Brazilian organization for crohn's and colitis
Par Flores C, Penna FGC, Imbrizi M et 19 autres.
Contenu en anglais
Résumé
Background
Biologics improve outcomes in inflammatory bowel disease, but high costs restrict access and strain healthcare resources. Biosimilars lower costs, expand access, and support sustainable IBD care.
Objective
Provide clear, evidence-based answers on biosimilar use in IBD across clinical, therapeutic, and economic domains to guide safe implementation and informed decision-making.